106 related articles for article (PubMed ID: 11906179)
21. The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.
Georgescu MM; Kirsch KH; Akagi T; Shishido T; Hanafusa H
Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10182-7. PubMed ID: 10468583
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
Zhou D; Masri S; Ye JJ; Chen S
Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
[TBL] [Abstract][Full Text] [Related]
23. Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
Soria JC; Lee HY; Lee JI; Wang L; Issa JP; Kemp BL; Liu DD; Kurie JM; Mao L; Khuri FR
Clin Cancer Res; 2002 May; 8(5):1178-84. PubMed ID: 12006535
[TBL] [Abstract][Full Text] [Related]
24. Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN.
Agrawal S; Pilarski R; Eng C
Hum Mol Genet; 2005 Aug; 14(16):2459-68. PubMed ID: 16014636
[TBL] [Abstract][Full Text] [Related]
25. Mutation and allelic loss of the PTEN/MMAC1 gene in primary and metastatic melanoma biopsies.
Birck A; Ahrenkiel V; Zeuthen J; Hou-Jensen K; Guldberg P
J Invest Dermatol; 2000 Feb; 114(2):277-80. PubMed ID: 10651986
[TBL] [Abstract][Full Text] [Related]
26. Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma.
Hu TH; Huang CC; Lin PR; Chang HW; Ger LP; Lin YW; Changchien CS; Lee CM; Tai MH
Cancer; 2003 Apr; 97(8):1929-40. PubMed ID: 12673720
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional analysis of the PTEN/MMAC1 pseudogene, psiPTEN.
Fujii GH; Morimoto AM; Berson AE; Bolen JB
Oncogene; 1999 Mar; 18(9):1765-9. PubMed ID: 10208437
[TBL] [Abstract][Full Text] [Related]
28. Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue.
Sebastian S; Takayama K; Shozu M; Bulun SE
Mol Endocrinol; 2002 Oct; 16(10):2243-54. PubMed ID: 12351690
[TBL] [Abstract][Full Text] [Related]
29. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer.
Frisk T; Foukakis T; Dwight T; Lundberg J; Höög A; Wallin G; Eng C; Zedenius J; Larsson C
Genes Chromosomes Cancer; 2002 Sep; 35(1):74-80. PubMed ID: 12203792
[TBL] [Abstract][Full Text] [Related]
30. Genetic interactions between Pten and p53 in radiation-induced lymphoma development.
Mao JH; Wu D; Perez-Losada J; Nagase H; DelRosario R; Balmain A
Oncogene; 2003 Nov; 22(52):8379-85. PubMed ID: 14627978
[TBL] [Abstract][Full Text] [Related]
31. Analysis of PTEN mutations and deletions in B-cell non-Hodgkin's lymphomas.
Butler MP; Wang SI; Chaganti RS; Parsons R; Dalla-Favera R
Genes Chromosomes Cancer; 1999 Apr; 24(4):322-7. PubMed ID: 10092130
[TBL] [Abstract][Full Text] [Related]
32. Functional evaluation of p53 and PTEN gene mutations in gliomas.
Kato H; Kato S; Kumabe T; Sonoda Y; Yoshimoto T; Kato S; Han SY; Suzuki T; Shibata H; Kanamaru R; Ishioka C
Clin Cancer Res; 2000 Oct; 6(10):3937-43. PubMed ID: 11051241
[TBL] [Abstract][Full Text] [Related]
33. Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.
Maxwell GL; Risinger JI; Gumbs C; Shaw H; Bentley RC; Barrett JC; Berchuck A; Futreal PA
Cancer Res; 1998 Jun; 58(12):2500-3. PubMed ID: 9635567
[TBL] [Abstract][Full Text] [Related]
34. [Cowden disease and the PTEN gene: a successfully clinical and biological combined approach].
Longy M
Bull Cancer; 2001 Dec; 88(12):1153-8. PubMed ID: 11792608
[TBL] [Abstract][Full Text] [Related]
35. Absence of PTEN/MMAC1 pseudogene in mice.
Kwabi-Addo B; Thompson TC; Ittmann M
DNA Cell Biol; 2000 May; 19(5):301-5. PubMed ID: 10855797
[TBL] [Abstract][Full Text] [Related]
36. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity.
Hlobilkova A; Guldberg P; Thullberg M; Zeuthen J; Lukas J; Bartek J
Exp Cell Res; 2000 May; 256(2):571-7. PubMed ID: 10772829
[TBL] [Abstract][Full Text] [Related]
37. Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors.
Hsieh MC; Lin SF; Shin SJ; Liu TC; Chang JG; Lee JP
Kaohsiung J Med Sci; 2000 Jan; 16(1):9-12. PubMed ID: 10741010
[TBL] [Abstract][Full Text] [Related]
38. The PTEN/MMAC1 tumor suppressor induces cell death that is rescued by the AKT/protein kinase B oncogene.
Li J; Simpson L; Takahashi M; Miliaresis C; Myers MP; Tonks N; Parsons R
Cancer Res; 1998 Dec; 58(24):5667-72. PubMed ID: 9865719
[TBL] [Abstract][Full Text] [Related]
39. PTEN and myotubularin: novel phosphoinositide phosphatases.
Maehama T; Taylor GS; Dixon JE
Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
[TBL] [Abstract][Full Text] [Related]
40. Genetic alterations of the tumor suppressor gene PTEN/MMAC1 in human brain metastases.
Hahn M; Wieland I; Koufaki ON; Görgens H; Sobottka SB; Schackert G; Schackert HK
Clin Cancer Res; 1999 Sep; 5(9):2431-7. PubMed ID: 10499615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
